Volume 7, Number 1
Abstinence, Anticipation, Reduction, and Treatment (AART): A Stepwise Approach to the Management of Atypical Antipsychotic Side Effects; Single Enantiomer Drugs: Should They Be Developed?; Anxious-Depressive Comorbidity: Effects on HPA Axis and CNS Noradrenergic Functions; Serotonin and Norepinephrine Transporter Binding Profile of SSRIs; Cytokines and Late-life Depression; The CATIE Study and Its Implications for Antipsychotic Drug Use

Volume 6, Number 6
How Solid Is the Evidence for the Efficacy of Mood Stabilizers in Bipolar Disorder?; Pharmacologic Management of Borderline Personality Disorder: A Case Study; Inappropriate Medication Use in the Elderly; Metabolic and Endocrine Effects of Sleep Deprivation; Reliability and Risks of Generic Psychopharmacologic Agents

Volume 6, Number 5
Objective Measures of Activity and Attention in the Differential Diagnosis of Psychiatric Disorders of Childhood; Integrated Pharmacologic Treatment of Attention-Deficit Hyperactivity Disorder (ADHD); Nonstimulant Therapies for ADHD in Children and Adults; Treatment of Comorbidity in Conduct Disorder with ADHD; Discussion on Integrated Pharmacologic Treatment of ADHD

Volume 6, Number 4
The Management of Fatigue in Depressed Patients; Genetics and Psychopharmacology; Augmentation of Standard Antidepressants With Atypical Antipsychotic Agents for Treatment-resistant Major Depressive Disorder; Study Designs and Outcomes in Antidepressant Clinical Trials; Long-term Benefits of Early Pharmacologic Treatment in Alzheimer's Disease